nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Prednisone—chronic obstructive pulmonary disease	0.627	1	CpDpCtD
Sumatriptan—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0564	0.405	CbGbCtD
Sumatriptan—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0533	0.382	CbGbCtD
Sumatriptan—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0152	0.109	CbGbCtD
Sumatriptan—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0144	0.103	CbGbCtD
Sumatriptan—Rizatriptan—CYP1A2—chronic obstructive pulmonary disease	0.00098	0.229	CrCbGaD
Sumatriptan—Zolmitriptan—CYP1A2—chronic obstructive pulmonary disease	0.000897	0.209	CrCbGaD
Sumatriptan—Melatonin—MPO—chronic obstructive pulmonary disease	0.000794	0.185	CrCbGaD
Sumatriptan—Almotriptan—CYP1A2—chronic obstructive pulmonary disease	0.00068	0.159	CrCbGaD
Sumatriptan—Melatonin—CYP1A1—chronic obstructive pulmonary disease	0.000476	0.111	CrCbGaD
Sumatriptan—Melatonin—CYP1A2—chronic obstructive pulmonary disease	0.000459	0.107	CrCbGaD
Sumatriptan—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000874	CcSEcCtD
Sumatriptan—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000874	CcSEcCtD
Sumatriptan—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00016	0.000872	CcSEcCtD
Sumatriptan—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000871	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.000868	CcSEcCtD
Sumatriptan—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000865	CcSEcCtD
Sumatriptan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.000857	CcSEcCtD
Sumatriptan—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.000857	CcSEcCtD
Sumatriptan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000157	0.000857	CcSEcCtD
Sumatriptan—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000157	0.000857	CcSEcCtD
Sumatriptan—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000856	CcSEcCtD
Sumatriptan—Infection—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000851	CcSEcCtD
Sumatriptan—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000851	CcSEcCtD
Sumatriptan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000844	CcSEcCtD
Sumatriptan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000844	CcSEcCtD
Sumatriptan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000844	CcSEcCtD
Sumatriptan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.000843	CcSEcCtD
Sumatriptan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000841	CcSEcCtD
Sumatriptan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00084	CcSEcCtD
Sumatriptan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00084	CcSEcCtD
Sumatriptan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.000839	CcSEcCtD
Sumatriptan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000154	0.000839	CcSEcCtD
Sumatriptan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000154	0.000839	CcSEcCtD
Sumatriptan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.000836	CcSEcCtD
Sumatriptan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000153	0.000836	CcSEcCtD
Sumatriptan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000834	CcSEcCtD
Sumatriptan—Infection—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000834	CcSEcCtD
Sumatriptan—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000832	CcSEcCtD
Sumatriptan—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000832	CcSEcCtD
Sumatriptan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.000829	CcSEcCtD
Sumatriptan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000825	CcSEcCtD
Sumatriptan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000151	0.000823	CcSEcCtD
Sumatriptan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000822	CcSEcCtD
Sumatriptan—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000821	CcSEcCtD
Sumatriptan—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000149	0.000815	CcSEcCtD
Sumatriptan—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000812	CcSEcCtD
Sumatriptan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000809	CcSEcCtD
Sumatriptan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000809	CcSEcCtD
Sumatriptan—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000804	CcSEcCtD
Sumatriptan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000801	CcSEcCtD
Sumatriptan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000801	CcSEcCtD
Sumatriptan—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.0008	CcSEcCtD
Sumatriptan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.000796	CcSEcCtD
Sumatriptan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000796	CcSEcCtD
Sumatriptan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000793	CcSEcCtD
Sumatriptan—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000792	CcSEcCtD
Sumatriptan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000789	CcSEcCtD
Sumatriptan—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000786	CcSEcCtD
Sumatriptan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000143	0.000782	CcSEcCtD
Sumatriptan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000782	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.000781	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000143	0.000781	CcSEcCtD
Sumatriptan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.00077	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00014	0.000765	CcSEcCtD
Sumatriptan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000764	CcSEcCtD
Sumatriptan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000764	CcSEcCtD
Sumatriptan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000762	CcSEcCtD
Sumatriptan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000762	CcSEcCtD
Sumatriptan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000756	CcSEcCtD
Sumatriptan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000753	CcSEcCtD
Sumatriptan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.000751	CcSEcCtD
Sumatriptan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000746	CcSEcCtD
Sumatriptan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.000744	CcSEcCtD
Sumatriptan—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000743	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00074	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00074	CcSEcCtD
Sumatriptan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000739	CcSEcCtD
Sumatriptan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000739	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000737	CcSEcCtD
Sumatriptan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000733	CcSEcCtD
Sumatriptan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000733	CcSEcCtD
Sumatriptan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000733	CcSEcCtD
Sumatriptan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000733	CcSEcCtD
Sumatriptan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000726	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000724	CcSEcCtD
Sumatriptan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000723	CcSEcCtD
Sumatriptan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000721	CcSEcCtD
Sumatriptan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000719	CcSEcCtD
Sumatriptan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000718	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000717	CcSEcCtD
Sumatriptan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000131	0.000716	CcSEcCtD
Sumatriptan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000713	CcSEcCtD
Sumatriptan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00071	CcSEcCtD
Sumatriptan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.000709	CcSEcCtD
Sumatriptan—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000707	CcSEcCtD
Sumatriptan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.000706	CcSEcCtD
Sumatriptan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000129	0.000706	CcSEcCtD
Sumatriptan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000129	0.000705	CcSEcCtD
Sumatriptan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000703	CcSEcCtD
Sumatriptan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000129	0.000702	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000701	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000701	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000698	CcSEcCtD
Sumatriptan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000697	CcSEcCtD
Sumatriptan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000692	CcSEcCtD
Sumatriptan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000692	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000686	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000686	CcSEcCtD
Sumatriptan—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000686	CcSEcCtD
Sumatriptan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000125	0.000681	CcSEcCtD
Sumatriptan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.000681	CcSEcCtD
Sumatriptan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000677	CcSEcCtD
Sumatriptan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000677	CcSEcCtD
Sumatriptan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000677	CcSEcCtD
Sumatriptan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000677	CcSEcCtD
Sumatriptan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.000675	CcSEcCtD
Sumatriptan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.000669	CcSEcCtD
Sumatriptan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.000669	CcSEcCtD
Sumatriptan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000122	0.000669	CcSEcCtD
Sumatriptan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000667	CcSEcCtD
Sumatriptan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000667	CcSEcCtD
Sumatriptan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.000665	CcSEcCtD
Sumatriptan—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000665	CcSEcCtD
Sumatriptan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000663	CcSEcCtD
Sumatriptan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000663	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000661	CcSEcCtD
Sumatriptan—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000656	CcSEcCtD
Sumatriptan—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000653	CcSEcCtD
Sumatriptan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000643	CcSEcCtD
Sumatriptan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000639	CcSEcCtD
Sumatriptan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000639	CcSEcCtD
Sumatriptan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000631	CcSEcCtD
Sumatriptan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000631	CcSEcCtD
Sumatriptan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000115	0.000631	CcSEcCtD
Sumatriptan—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000629	CcSEcCtD
Sumatriptan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000113	0.000618	CcSEcCtD
Sumatriptan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000615	CcSEcCtD
Sumatriptan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000615	CcSEcCtD
Sumatriptan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000606	CcSEcCtD
Sumatriptan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000606	CcSEcCtD
Sumatriptan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000602	CcSEcCtD
Sumatriptan—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000597	CcSEcCtD
Sumatriptan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000596	CcSEcCtD
Sumatriptan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000594	CcSEcCtD
Sumatriptan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000586	CcSEcCtD
Sumatriptan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000586	CcSEcCtD
Sumatriptan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000583	CcSEcCtD
Sumatriptan—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000581	CcSEcCtD
Sumatriptan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00058	CcSEcCtD
Sumatriptan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000574	CcSEcCtD
Sumatriptan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000572	CcSEcCtD
Sumatriptan—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000568	CcSEcCtD
Sumatriptan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000567	CcSEcCtD
Sumatriptan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000567	CcSEcCtD
Sumatriptan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000555	CcSEcCtD
Sumatriptan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000553	CcSEcCtD
Sumatriptan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.97e-05	0.000545	CcSEcCtD
Sumatriptan—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.97e-05	0.000545	CcSEcCtD
Sumatriptan—Rash—Arformoterol—chronic obstructive pulmonary disease	9.89e-05	0.00054	CcSEcCtD
Sumatriptan—Rash—Formoterol—chronic obstructive pulmonary disease	9.89e-05	0.00054	CcSEcCtD
Sumatriptan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.88e-05	0.00054	CcSEcCtD
Sumatriptan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.88e-05	0.00054	CcSEcCtD
Sumatriptan—Weight increased—Prednisone—chronic obstructive pulmonary disease	9.88e-05	0.00054	CcSEcCtD
Sumatriptan—Headache—Arformoterol—chronic obstructive pulmonary disease	9.83e-05	0.000537	CcSEcCtD
Sumatriptan—Headache—Formoterol—chronic obstructive pulmonary disease	9.83e-05	0.000537	CcSEcCtD
Sumatriptan—Weight decreased—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000536	CcSEcCtD
Sumatriptan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.79e-05	0.000535	CcSEcCtD
Sumatriptan—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.000535	CcSEcCtD
Sumatriptan—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.77e-05	0.000534	CcSEcCtD
Sumatriptan—Rash—Montelukast—chronic obstructive pulmonary disease	9.69e-05	0.000529	CcSEcCtD
Sumatriptan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.68e-05	0.000529	CcSEcCtD
Sumatriptan—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.66e-05	0.000527	CcSEcCtD
Sumatriptan—Depression—Prednisone—chronic obstructive pulmonary disease	9.65e-05	0.000527	CcSEcCtD
Sumatriptan—Headache—Montelukast—chronic obstructive pulmonary disease	9.62e-05	0.000526	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000521	CcSEcCtD
Sumatriptan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.51e-05	0.000519	CcSEcCtD
Sumatriptan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.000518	CcSEcCtD
Sumatriptan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.42e-05	0.000514	CcSEcCtD
Sumatriptan—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.39e-05	0.000513	CcSEcCtD
Sumatriptan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.35e-05	0.000511	CcSEcCtD
Sumatriptan—Rash—Salbutamol—chronic obstructive pulmonary disease	9.34e-05	0.00051	CcSEcCtD
Sumatriptan—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.33e-05	0.00051	CcSEcCtD
Sumatriptan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.33e-05	0.00051	CcSEcCtD
Sumatriptan—Nausea—Formoterol—chronic obstructive pulmonary disease	9.32e-05	0.000509	CcSEcCtD
Sumatriptan—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.32e-05	0.000509	CcSEcCtD
Sumatriptan—Headache—Salbutamol—chronic obstructive pulmonary disease	9.28e-05	0.000507	CcSEcCtD
Sumatriptan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.15e-05	0.0005	CcSEcCtD
Sumatriptan—Nausea—Montelukast—chronic obstructive pulmonary disease	9.13e-05	0.000498	CcSEcCtD
Sumatriptan—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.02e-05	0.000493	CcSEcCtD
Sumatriptan—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.99e-05	0.000491	CcSEcCtD
Sumatriptan—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.000483	CcSEcCtD
Sumatriptan—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.8e-05	0.00048	CcSEcCtD
Sumatriptan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.76e-05	0.000478	CcSEcCtD
Sumatriptan—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	8.73e-05	0.000477	CcSEcCtD
Sumatriptan—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.69e-05	0.000475	CcSEcCtD
Sumatriptan—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.65e-05	0.000472	CcSEcCtD
Sumatriptan—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.000466	CcSEcCtD
Sumatriptan—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.49e-05	0.000464	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.49e-05	0.000464	CcSEcCtD
Sumatriptan—Shock—Prednisolone—chronic obstructive pulmonary disease	8.36e-05	0.000456	CcSEcCtD
Sumatriptan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.29e-05	0.000453	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.21e-05	0.000449	CcSEcCtD
Sumatriptan—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000443	CcSEcCtD
Sumatriptan—Flushing—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.00044	CcSEcCtD
Sumatriptan—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000431	CcSEcCtD
Sumatriptan—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.000429	CcSEcCtD
Sumatriptan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000424	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.63e-05	0.000417	CcSEcCtD
Sumatriptan—Erythema—Prednisone—chronic obstructive pulmonary disease	7.56e-05	0.000413	CcSEcCtD
Sumatriptan—Pain—Prednisolone—chronic obstructive pulmonary disease	7.26e-05	0.000397	CcSEcCtD
Sumatriptan—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.02e-05	0.000383	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7e-05	0.000382	CcSEcCtD
Sumatriptan—Anaemia—Prednisone—chronic obstructive pulmonary disease	6.99e-05	0.000382	CcSEcCtD
Sumatriptan—Agitation—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.00038	CcSEcCtD
Sumatriptan—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000377	CcSEcCtD
Sumatriptan—Malaise—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000373	CcSEcCtD
Sumatriptan—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.000371	CcSEcCtD
Sumatriptan—Syncope—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.00037	CcSEcCtD
Sumatriptan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.75e-05	0.000369	CcSEcCtD
Sumatriptan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000363	CcSEcCtD
Sumatriptan—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000358	CcSEcCtD
Sumatriptan—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000357	CcSEcCtD
Sumatriptan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000352	CcSEcCtD
Sumatriptan—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000352	CcSEcCtD
Sumatriptan—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.00035	CcSEcCtD
Sumatriptan—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000347	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.26e-05	0.000342	CcSEcCtD
Sumatriptan—Oedema—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000337	CcSEcCtD
Sumatriptan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000337	CcSEcCtD
Sumatriptan—Infection—Prednisone—chronic obstructive pulmonary disease	6.13e-05	0.000335	CcSEcCtD
Sumatriptan—Shock—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000332	CcSEcCtD
Sumatriptan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.05e-05	0.000331	CcSEcCtD
Sumatriptan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000329	CcSEcCtD
Sumatriptan—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6e-05	0.000327	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.000326	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000307	CcSEcCtD
Sumatriptan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.62e-05	0.000307	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000303	CcSEcCtD
Sumatriptan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000293	CcSEcCtD
Sumatriptan—Rash—Prednisolone—chronic obstructive pulmonary disease	5.36e-05	0.000293	CcSEcCtD
Sumatriptan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.35e-05	0.000292	CcSEcCtD
Sumatriptan—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.000291	CcSEcCtD
Sumatriptan—Headache—Prednisolone—chronic obstructive pulmonary disease	5.32e-05	0.000291	CcSEcCtD
Sumatriptan—Constipation—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000288	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000278	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000276	CcSEcCtD
Sumatriptan—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.05e-05	0.000276	CcSEcCtD
Sumatriptan—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.9e-05	0.000268	CcSEcCtD
Sumatriptan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000267	CcSEcCtD
Sumatriptan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000267	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.55e-05	0.000248	CcSEcCtD
Sumatriptan—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000242	CcSEcCtD
Sumatriptan—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000239	CcSEcCtD
Sumatriptan—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.34e-05	0.000934	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	4.34e-05	0.000934	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.32e-05	0.000929	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.26e-05	0.000917	CbGpPWpGaD
Sumatriptan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.000231	CcSEcCtD
Sumatriptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.22e-05	0.000909	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.17e-05	0.000898	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.13e-05	0.000889	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.09e-05	0.000879	CbGpPWpGaD
Sumatriptan—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000223	CcSEcCtD
Sumatriptan—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	4.07e-05	0.000876	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.04e-05	0.00087	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.03e-05	0.000868	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.02e-05	0.000865	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	4.02e-05	0.000864	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.94e-05	0.000847	CbGpPWpGaD
Sumatriptan—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.92e-05	0.000214	CcSEcCtD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.91e-05	0.000842	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.91e-05	0.000842	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.9e-05	0.00084	CbGpPWpGaD
Sumatriptan—Rash—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000213	CcSEcCtD
Sumatriptan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000212	CcSEcCtD
Sumatriptan—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.88e-05	0.000835	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.87e-05	0.000833	CbGpPWpGaD
Sumatriptan—Headache—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000211	CcSEcCtD
Sumatriptan—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.81e-05	0.00082	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.76e-05	0.000809	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.73e-05	0.000804	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.69e-05	0.000794	CbGpPWpGaD
Sumatriptan—Nausea—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.0002	CcSEcCtD
Sumatriptan—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.66e-05	0.000787	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.65e-05	0.000786	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.61e-05	0.000778	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.55e-05	0.000764	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.49e-05	0.000751	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.46e-05	0.000745	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.46e-05	0.000744	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.43e-05	0.000739	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.43e-05	0.000739	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.42e-05	0.000735	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.41e-05	0.000733	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.39e-05	0.00073	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.37e-05	0.000725	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.36e-05	0.000722	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.35e-05	0.00072	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.29e-05	0.000708	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.22e-05	0.000693	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.22e-05	0.000692	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.21e-05	0.000691	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.2e-05	0.000689	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.18e-05	0.000684	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.13e-05	0.000674	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.12e-05	0.000671	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.04e-05	0.000654	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.02e-05	0.000649	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.99e-05	0.000643	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.99e-05	0.000643	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.98e-05	0.000641	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.94e-05	0.000633	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.92e-05	0.000629	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.88e-05	0.000619	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.81e-05	0.000605	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.81e-05	0.000605	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.77e-05	0.000596	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.76e-05	0.000594	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.75e-05	0.000593	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.75e-05	0.000593	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.75e-05	0.000592	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.74e-05	0.000589	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.7e-05	0.000581	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.67e-05	0.000574	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.61e-05	0.000562	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.6e-05	0.00056	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.57e-05	0.000553	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.57e-05	0.000553	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.55e-05	0.00055	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	2.54e-05	0.000546	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.52e-05	0.000542	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.5e-05	0.000538	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.48e-05	0.000535	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.47e-05	0.000531	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.45e-05	0.000528	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.43e-05	0.000523	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.42e-05	0.00052	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.37e-05	0.00051	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.34e-05	0.000504	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.34e-05	0.000503	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.000498	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.3e-05	0.000496	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.000492	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.29e-05	0.000492	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.26e-05	0.000485	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.24e-05	0.000482	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.23e-05	0.00048	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.23e-05	0.000479	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.19e-05	0.000472	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.19e-05	0.000472	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.18e-05	0.00047	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.17e-05	0.000467	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.17e-05	0.000467	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.16e-05	0.000464	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.15e-05	0.000464	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.00046	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000459	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.11e-05	0.000455	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.1e-05	0.000452	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000451	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.08e-05	0.000447	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.06e-05	0.000443	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.02e-05	0.000434	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.01e-05	0.000433	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.01e-05	0.000432	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.99e-05	0.000428	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.98e-05	0.000426	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000424	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.96e-05	0.000421	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.94e-05	0.000417	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.92e-05	0.000414	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.92e-05	0.000414	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.92e-05	0.000413	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.92e-05	0.000413	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.91e-05	0.000411	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.89e-05	0.000408	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.87e-05	0.000403	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.84e-05	0.000396	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.000396	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.82e-05	0.000392	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.8e-05	0.000388	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.78e-05	0.000383	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.77e-05	0.00038	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.76e-05	0.00038	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.000378	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.75e-05	0.000376	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.74e-05	0.000375	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.73e-05	0.000373	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.73e-05	0.000372	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.68e-05	0.000362	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.67e-05	0.00036	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.66e-05	0.000356	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.000355	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.64e-05	0.000353	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.64e-05	0.000352	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.62e-05	0.000349	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000349	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.000342	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.000339	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.57e-05	0.000339	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000335	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000334	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.55e-05	0.000333	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.54e-05	0.000332	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.53e-05	0.00033	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.53e-05	0.000329	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.52e-05	0.000327	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.000325	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.5e-05	0.000323	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.5e-05	0.000323	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.44e-05	0.00031	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.43e-05	0.000308	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000308	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.43e-05	0.000307	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.41e-05	0.000304	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.4e-05	0.000302	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.4e-05	0.000301	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.000297	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.36e-05	0.000293	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.35e-05	0.000291	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.35e-05	0.00029	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.33e-05	0.000287	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.32e-05	0.000285	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.32e-05	0.000283	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.28e-05	0.000276	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000273	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.26e-05	0.00027	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.25e-05	0.000269	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.21e-05	0.000259	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.19e-05	0.000255	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.18e-05	0.000255	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.18e-05	0.000253	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.17e-05	0.000252	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.16e-05	0.000249	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000245	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.000234	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.08e-05	0.000233	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.000232	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.07e-05	0.00023	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.07e-05	0.00023	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.05e-05	0.000227	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000227	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.04e-05	0.000224	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000224	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000222	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.03e-05	0.000222	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.03e-05	0.000221	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000217	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.01e-05	0.000217	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.93e-06	0.000214	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.86e-06	0.000212	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.85e-06	0.000212	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.74e-06	0.00021	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	9.73e-06	0.000209	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.61e-06	0.000207	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.57e-06	0.000206	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.45e-06	0.000203	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.41e-06	0.000202	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.39e-06	0.000202	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.3e-06	0.0002	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.03e-06	0.000194	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	9.01e-06	0.000194	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.62e-06	0.000185	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.52e-06	0.000183	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.4e-06	0.000181	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.34e-06	0.00018	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.22e-06	0.000177	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.18e-06	0.000176	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.11e-06	0.000175	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.1e-06	0.000174	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.93e-06	0.000171	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.86e-06	0.000169	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.71e-06	0.000166	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.56e-06	0.000163	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.55e-06	0.000162	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.51e-06	0.000162	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.49e-06	0.000161	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.17e-06	0.000154	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.16e-06	0.000154	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.92e-06	0.000149	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.91e-06	0.000149	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.78e-06	0.000146	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.59e-06	0.000142	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.36e-06	0.000137	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.35e-06	0.000137	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.29e-06	0.000135	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.23e-06	0.000134	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.22e-06	0.000134	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.1e-06	0.000131	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.04e-06	0.00013	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.75e-06	0.000124	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.58e-06	0.00012	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.31e-06	0.000114	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.23e-06	0.000113	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.16e-06	0.000111	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.12e-06	0.00011	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.05e-06	0.000109	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.87e-06	0.000105	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.79e-06	0.000103	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.74e-06	0.000102	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.69e-06	0.000101	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.66e-06	0.0001	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.65e-06	0.0001	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.53e-06	9.75e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.16e-06	8.95e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.08e-06	8.78e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.9e-06	8.39e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.57e-06	7.68e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.43e-06	7.37e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.14e-06	6.75e-05	CbGpPWpGaD
